About
ARCex non-invasive spinal cord stimulation
Areas of Focus
Categories
Uncategorized Medical Device
Team (19)
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
4
As Collaborator
2
Total Enrollment
174
By Phase
NA: 6
By Status
NOT_YET_RECRUITING: 2RECRUITING: 2COMPLETED: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07147296Lead Sponsor
ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury
NANot yet recruiting
60 participants
Started: Sep 30, 2025 · Completed: Mar 31, 2029
NCT06140706Collaborator
Feasibility of Home Based Transcutaneous Spinal Cord Stimulation for Persons With SCI
NANot yet recruiting
10 participants
Started: Sep 1, 2025 · Completed: Dec 31, 2027
NCT06494020Collaborator
Task Practice and Spinal Cord Stimulation
NARecruiting
6 participants
Started: Sep 1, 2024 · Completed: Oct 1, 2027
NCT05941819Lead Sponsor
ARC Therapy to Restore Hemodynamic Stability and Trunk Control in People With Spinal Cord Injury
NARecruiting
16 participants
Started: Sep 5, 2023 · Completed: Sep 30, 2025
NCT05284201Lead Sponsor
LIFT Home Study of Non-Invasive ARC Therapy for Spinal Cord Injury
NACompleted
17 participants
Started: Mar 3, 2022 · Completed: Sep 13, 2022
Locations (1)
Headquarters
Eindhoven, Netherlands
Map
Loading map...